Autopsy report · NCT04232709

Evaluating the CAREchart@Home™ Program for Enhancing After-hours Cancer Care

“Due to unforeseen circumstances, the funder decided to discontinue all funding.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month after it had already started.
• Ran for about 1 year 3 months before it stopped.
• 105 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Women's College Hospital

Sponsor type

University, hospital or other

Conditions

Cancer

Interventions

Shared electronic patient record

Participants

105

Sites

1

Countries

Canada

Trials that died the same way

• Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)
  “Discontinuation of funding” (79% match in meaning)
• Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
  “Funding was stoppped by grantor.” (73% match in meaning)
• A Study of APR-246 in Oesophageal Cancer
  “Funding ceased” (72% match in meaning)
• Safety Study of Nebivolol for COPD Patients
  “Funding was discontinued.” (71% match in meaning)
• Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
  “Funding terminated by funding source.” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.